About this trial
Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, which could nevertheless impact diagnosis by identifying a profile of at-risk patients, and consequently, their management.
The goal of this present study is to describe the differences in care pathways between men and women with Fabry's disease, distinguishing entry via symptoms or family screening through a non-interventional study based on a questionnaire sent to patients and on the collection of medical data at the time of diagnosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patient diagnosed with Fabry's disease
Disqualifiers
Minor patients
Trial population
Any adult patients with a Fabry's disease diagnosis
Trial design
Cohort
Prospective
Treatments tested in this trial
Self-questionnaire
Other interventionMedical data of Fabry's disease
Treatment groups
Trial outcomes
Primary outcomes
Diagnostic time in care pathways between men and women with Fabry's disease
The average diagnostic time, compared between men and women, and the diagnostic methods (entry point into the disease), compared according to sex.
Comparison of diagnostic methods between men and women
Data collection at the point of entry into the disease: via symptoms or family screening
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: